
Alife Health
Building tools to improve the equity and efficacy of IVF through artificial intelligence.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
investor investor investor investor investor investor investor investor investor | €0.0 | round | |
* | $22.0m | Series A | |
Total Funding | 000k |
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | 40 % | 81 % |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Alife Health is a technology startup that operates in the healthcare sector, specifically focusing on improving the In Vitro Fertilization (IVF) process. The company uses artificial intelligence (AI) to provide data-driven insights that help doctors make informed decisions about IVF procedures. The primary clients of Alife Health are healthcare professionals, including clinicians, embryologists, and clinic managers, who use the company's platform, Alife Assist, to optimize each step of the IVF process.
The company's business model revolves around the development and provision of AI software that analyzes historical data to predict the most effective treatment plans for IVF patients. By doing so, Alife Health aims to improve the success rate of IVF procedures, thereby providing value to both healthcare professionals and patients. The company generates revenue by selling access to its software platform to healthcare providers.
Alife Health operates in the fertility treatment market, which is a growing sector due to increasing infertility rates and advancements in fertility treatments. The company's use of AI technology positions it well to capitalize on the trend towards data-driven decision making in healthcare.
Keywords: Alife Health, Healthcare, In Vitro Fertilization, Artificial Intelligence, Data-Driven Insights, Clinicians, Embryologists, Clinic Managers, Fertility Treatment Market, Software Platform.